OBJECTIVE: To review the anesthetic management for percutaneous transcatheter closure of perimembranous @entity1757 ( @entity1757 ) with an Amplatzer asymmetric occluder device and to highlight the hemodynamic effects and potential complications associated with its delivery. DESIGN: Retrospective review of prospectively collected data. SETTING: University-affiliated teaching hospital. @entity1 : Nine consecutive @entity1 undergoing elective percutaneous transcatheter closure of perimembranous @entity1757 . INTERVENTIONS: General anesthesia with @entity2614 for cardiac catheterization and percutaneous transcatheter device placement. MEASUREMENTS AND MAIN RESULTS: Ten anesthetics were delivered in 9 @entity1 ages 23 to 65 months with perimembranous @entity1757 for attempted placement of an Amplatzer asymmetric device. The device was successfully placed in 7 @entity1 . In 1 @entity1 the device embolized to the right femoral artery, and was retrieved with a bioptome. Fluoroscopy time (59.8 +/- 17.24 min) was prolonged compared to that in other studies of placement of this device. All @entity1 had episodes of @entity943 and hemodynamic disturbance. @entity943 ranged from @entity8630 events to various degrees of @entity713 . Complete @entity616 occurred during the procedure in 1 @entity1 and after the procedure in another @entity1 . @entity551 episodes occurred in 7 @entity1 , and were attributed to @entity943 in 5 @entity1 and @entity3485 in 2 @entity1 . Two @entity1 were given blood transfusions after the procedure because they had signs of @entity3485 and a greater than 10% decrease in hemoglobin levels. CONCLUSIONS: Anesthesia for perimembranous @entity1757 occluder placement is associated with @entity1344 , @entity943 , prolonged procedure times, and inevitable and sometimes substantial @entity190 .

Anesthesia for percutaneous transcatheter closure of perimembranous XXXX .

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'patient', 'PARTICIPANTS'] @entity1344 :: ('MESH:D043171', 'Disease') :: ['hemodynamic instability'] @entity8630 :: ('MESH:D013612', 'Disease') :: ['atrial or ventricular ectopic'] @entity713 :: ('MESH:D054537', 'Disease') :: ['atrioventricular block'] @entity190 :: ('MESH:D006473', 'Disease') :: ['blood loss'] @entity1757 :: ('MESH:D006345', 'Disease') :: ['VSD', 'ventricular septal defect'] @entity551 :: ('MESH:D007022', 'Disease') :: ['Hypotensive'] @entity3485 :: ('MESH:D020896', 'Disease') :: ['hypovolemia'] @entity2614 :: ('MESH:C009250', 'Chemical') :: ['sevoflurane'] @entity943 :: ('MESH:D001145', 'Disease') :: ['arrhythmia', 'Arrhythmias', 'arrhythmias'] @entity616 :: ('MESH:D006327', 'Disease') :: ['heart block']
@entity1757 :: (MESH:D006345,Disease) :: ['ventricular septal defect']
